콜히친 (Korean Wikipedia)

Analysis of information sources in references of the Wikipedia article "콜히친" in Korean language version.

refsWebsite

Global rank Korean rank

11doi.org

2^nd place

3^rd place

11nih.gov

4^th place

3fda.gov

447^th place

433^rd place

2annals.org

low place

5,034^th place

2worldcat.org

5^th place

11^th place

1clinicaltherapeutics.com

low place

1web.archive.org

1^st place

1nps.org.au

low place

1drugs.com

399^th place

141^st place

1cochranelibrary.com

low place

8,529^th place

1bmj.com

1,226^th place

829^th place

1books.google.com

3^rd place

9^th place

annals.org

Shekelle, Paul G.; Newberry, Sydne J.; FitzGerald, John D.; Motala, Aneesa; O'Hanlon, Claire E.; Tariq, Abdul; Okunogbe, Adeyemi; Han, Dan; Shanman, Roberta (2017). “Management of gout: A systematic review in support of an American College of Physicians Clinical Practice Guideline”. 《Annals of Internal Medicine》 166 (1): 37–51. doi:10.7326/M16-0461. ISSN 0003-4819.
Qaseem, Amir; Harris, Russell P.; Forciea, Mary Ann (2017). “Management of acute and recurrent gout: A Clinical Practice Guideline From the American College of Physicians”. 《Annals of Internal Medicine》 166 (1): 58–68. doi:10.7326/M16-0570. ISSN 0003-4819.

bmj.com

ard.bmj.com

Graham W, Roberts JB (March 1953). “Intravenous colchicine in the management of gouty arthritis” (PDF). 《Annals of the Rheumatic Diseases》 12 (1): 16–9. doi:10.1136/ard.12.1.16. PMC 1030428. PMID 13031443.

books.google.com

Pelletier and Caventou (1820) "Examen chimique des plusieurs végétaux de la famille des colchicées, et du principe actif qu'ils renferment. [Cévadille (veratrum sabadilla) ; hellébore blanc (veratrum album) ; colchique commun (colchicum autumnale)]" (Chemical examination of several plants of the meadow saffron family, and of the active principle that they contain.) Annales de Chimie et de Physique, 14 : 69-81.

clinicaltherapeutics.com

Dalbeth N, Lauterio TJ, Wolfe HR (October 2014). “Mechanism of action of colchicine in the treatment of gout”. 《Clinical Therapeutics》 36 (10): 1465–79. doi:10.1016/j.clinthera.2014.07.017. PMID 25151572.

cochranelibrary.com

van Echteld I, Wechalekar MD, Schlesinger N, Buchbinder R, Aletaha D (August 2014). “Colchicine for acute gout”. 《The Cochrane Database of Systematic Reviews》 8 (8): CD006190. doi:10.1002/14651858.CD006190.pub2. PMID 25123076.

doi.org

dx.doi.org

Shekelle PG, Newberry SJ, FitzGerald JD, Motala A, O'Hanlon CE, Tariq A, 외. (January 2017). “Management of Gout: A Systematic Review in Support of an American College of Physicians Clinical Practice Guideline”. 《Annals of Internal Medicine》 166 (1): 37–51. doi:10.7326/M16-0461. PMID 27802478.
Dalbeth N, Lauterio TJ, Wolfe HR (October 2014). “Mechanism of action of colchicine in the treatment of gout”. 《Clinical Therapeutics》 36 (10): 1465–79. doi:10.1016/j.clinthera.2014.07.017. PMID 25151572.
Chen LX, Schumacher HR (October 2008). “Gout: an evidence-based review”. 《Journal of Clinical Rheumatology》 14 (5 Suppl): S55–62. doi:10.1097/RHU.0b013e3181896921. PMID 18830092.
van Echteld I, Wechalekar MD, Schlesinger N, Buchbinder R, Aletaha D (August 2014). “Colchicine for acute gout”. 《The Cochrane Database of Systematic Reviews》 8 (8): CD006190. doi:10.1002/14651858.CD006190.pub2. PMID 25123076.
Terkeltaub RA, Furst DE, Bennett K, Kook KA, Crockett RS, Davis MW (April 2010). “High versus low dosing of oral colchicine for early acute gout flare: Twenty-four-hour outcome of the first multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison colchicine study”. 《Arthritis and Rheumatism》 62 (4): 1060–8. doi:10.1002/art.27327. PMID 20131255.
Shekelle, Paul G.; Newberry, Sydne J.; FitzGerald, John D.; Motala, Aneesa; O'Hanlon, Claire E.; Tariq, Abdul; Okunogbe, Adeyemi; Han, Dan; Shanman, Roberta (2017). “Management of gout: A systematic review in support of an American College of Physicians Clinical Practice Guideline”. 《Annals of Internal Medicine》 166 (1): 37–51. doi:10.7326/M16-0461. ISSN 0003-4819.
Qaseem, Amir; Harris, Russell P.; Forciea, Mary Ann (2017). “Management of acute and recurrent gout: A Clinical Practice Guideline From the American College of Physicians”. 《Annals of Internal Medicine》 166 (1): 58–68. doi:10.7326/M16-0570. ISSN 0003-4819.
Cocco G, Chu DC, Pandolfi S (December 2010). “Colchicine in clinical medicine. A guide for internists”. 《European Journal of Internal Medicine》 21 (6): 503–8. doi:10.1016/j.ejim.2010.09.010. PMID 21111934.
Puéchal X, Terrier B, Mouthon L, Costedoat-Chalumeau N, Guillevin L, Le Jeunne C (March 2014). “Relapsing polychondritis”. 《Joint, Bone, Spine》 81 (2): 118–24. doi:10.1016/j.jbspin.2014.01.001. PMID 24556284.
Alabed S, Cabello JB, Irving GJ, Qintar M, Burls A (August 2014). “Colchicine for pericarditis”. 《The Cochrane Database of Systematic Reviews》 8 (8): CD010652. doi:10.1002/14651858.CD010652.pub2. PMID 25164988.
Graham W, Roberts JB (March 1953). “Intravenous colchicine in the management of gouty arthritis” (PDF). 《Annals of the Rheumatic Diseases》 12 (1): 16–9. doi:10.1136/ard.12.1.16. PMC 1030428. PMID 13031443.

drugs.com

“Colchicine”. Drugs.com. 2017년 1월 1일. 2018년 8월 19일에 확인함.

fda.gov

accessdata.fda.gov

“Colcrys (colchicine, USP) tablets 0.6 mg. Drug Approval Package”. US Food and Drug Administration. 2010년 2월 17일. 2018년 8월 19일에 확인함.
“Colcrys (colchicine). Summary review for regulatory action” (PDF). Center for Drug Evaluation and Research, US Food and Drug Administration. 2009년 7월 30일. 2018년 8월 19일에 확인함.

fda.gov

“Information for Healthcare Professionals: New Safety Information for Colchicine (marketed as Colcrys)”. 미국 식품의약국.

nih.gov

ncbi.nlm.nih.gov

Shekelle PG, Newberry SJ, FitzGerald JD, Motala A, O'Hanlon CE, Tariq A, 외. (January 2017). “Management of Gout: A Systematic Review in Support of an American College of Physicians Clinical Practice Guideline”. 《Annals of Internal Medicine》 166 (1): 37–51. doi:10.7326/M16-0461. PMID 27802478.
Dalbeth N, Lauterio TJ, Wolfe HR (October 2014). “Mechanism of action of colchicine in the treatment of gout”. 《Clinical Therapeutics》 36 (10): 1465–79. doi:10.1016/j.clinthera.2014.07.017. PMID 25151572.
Chen LX, Schumacher HR (October 2008). “Gout: an evidence-based review”. 《Journal of Clinical Rheumatology》 14 (5 Suppl): S55–62. doi:10.1097/RHU.0b013e3181896921. PMID 18830092.
Laubscher T, Dumont Z, Regier L, Jensen B (December 2009). “Taking the stress out of managing gout”. 《Canadian Family Physician》 55 (12): 1209–12. PMC 2793228. PMID 20008601.
van Echteld I, Wechalekar MD, Schlesinger N, Buchbinder R, Aletaha D (August 2014). “Colchicine for acute gout”. 《The Cochrane Database of Systematic Reviews》 8 (8): CD006190. doi:10.1002/14651858.CD006190.pub2. PMID 25123076.
Terkeltaub RA, Furst DE, Bennett K, Kook KA, Crockett RS, Davis MW (April 2010). “High versus low dosing of oral colchicine for early acute gout flare: Twenty-four-hour outcome of the first multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison colchicine study”. 《Arthritis and Rheumatism》 62 (4): 1060–8. doi:10.1002/art.27327. PMID 20131255.
Cocco G, Chu DC, Pandolfi S (December 2010). “Colchicine in clinical medicine. A guide for internists”. 《European Journal of Internal Medicine》 21 (6): 503–8. doi:10.1016/j.ejim.2010.09.010. PMID 21111934.
Puéchal X, Terrier B, Mouthon L, Costedoat-Chalumeau N, Guillevin L, Le Jeunne C (March 2014). “Relapsing polychondritis”. 《Joint, Bone, Spine》 81 (2): 118–24. doi:10.1016/j.jbspin.2014.01.001. PMID 24556284.
Alabed S, Cabello JB, Irving GJ, Qintar M, Burls A (August 2014). “Colchicine for pericarditis”. 《The Cochrane Database of Systematic Reviews》 8 (8): CD010652. doi:10.1002/14651858.CD010652.pub2. PMID 25164988.
Portincasa P (2016). “Colchicine, Biologic Agents and More for the Treatment of Familial Mediterranean Fever. The Old, the New, and the Rare”. 《Current Medicinal Chemistry》 23 (1): 60–86. PMID 26572612.
Graham W, Roberts JB (March 1953). “Intravenous colchicine in the management of gouty arthritis” (PDF). 《Annals of the Rheumatic Diseases》 12 (1): 16–9. doi:10.1136/ard.12.1.16. PMC 1030428. PMID 13031443.

nps.org.au

“Colchicine for acute gout: updated information about dosing and drug interactions”. National Prescribing Service, Australia. 2010년 5월 14일. 2012년 6월 30일에 원본 문서에서 보존된 문서. 2010년 5월 14일에 확인함.

web.archive.org

“Colchicine for acute gout: updated information about dosing and drug interactions”. National Prescribing Service, Australia. 2010년 5월 14일. 2012년 6월 30일에 원본 문서에서 보존된 문서. 2010년 5월 14일에 확인함.

worldcat.org

Shekelle, Paul G.; Newberry, Sydne J.; FitzGerald, John D.; Motala, Aneesa; O'Hanlon, Claire E.; Tariq, Abdul; Okunogbe, Adeyemi; Han, Dan; Shanman, Roberta (2017). “Management of gout: A systematic review in support of an American College of Physicians Clinical Practice Guideline”. 《Annals of Internal Medicine》 166 (1): 37–51. doi:10.7326/M16-0461. ISSN 0003-4819.
Qaseem, Amir; Harris, Russell P.; Forciea, Mary Ann (2017). “Management of acute and recurrent gout: A Clinical Practice Guideline From the American College of Physicians”. 《Annals of Internal Medicine》 166 (1): 58–68. doi:10.7326/M16-0570. ISSN 0003-4819.